ICPT - Intercept Pharmaceuticals Inc
IEX Last Trade
10.65
0.260 2.441%
Share volume: 789,330
Last Updated: Tue 08 Aug 2023 09:59:59 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$10.39
0.26
2.50%
Summary score
27%
Profitability
33%
Dept financing
46%
Liquidity
30%
Performance
16%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
24.94%
Return on assets
-5.44%
Return on sales
-47.73%
Return on invested capital
22.73%
Total debt ratio
117%
Debt ratio change over timeo
8.99%
Current Ratio
3.35%
Quick Ratio
3.35%
Cash Position Ratio
2.92%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
42.38%
Return on assets
-3.94%
Return on sales
-35.05%
Return on invested capital
-24.81%
Total debt ratio
84.17%
Debt ratio change over timeo
8.67%
Current Ratio
2.42%
Quick Ratio
2.42%
Cash Position Ratio
2.16%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
-8.68%
Return on assets
-1.47%
Return on sales
-8.5%
Return on invested capital
3.39%
Total debt ratio
86.06%
Debt ratio change over time
24.42%
Current Ratio
2.52%
Quick Ratio
2.52%
Cash Position Ratio
2.21%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.5%
Return on assets
-123.19%
Return on sales
-285.29%
Return on invested capital
1.45%
Total debt ratio
899.5%
Debt ratio change over time
8.99%
Current Ratio
24.11%
Quick Ratio
24.11%
Cash Position Ratio
20.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ICPT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 24.94% | 0% | 0% | -106.57% |
| Return on assets | -5.44% | 0% | 0% | -12.17% |
| Return on sales | -47.73% | 0% | 0% | -8133.27% |
| Return on invested capital | 22.73% | 0% | 0% | -41.1% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 117% | 0% | 0% | 80.46% |
| Debt ratio change over time | 8.99% | 0% | 0% | -0.75% |
| Dept financing | 50% | 0% | 0% | 17% |
| Current Ratio | 2.42% | 0% | 0% | 6.21% |
| Quick Ratio | 2.42% | 0% | 0% | 6.2% |
| Cash Position Ratio | 2.16% | 0% | 0% | 5.92% |
| Liquididy | 32% | 0% | 0% | 75% |
| Short-term ratios | ICPT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 42.38% | 0% | 0% | -327.32% |
| Return on assets | -3.94% | 0% | 0% | -17.01% |
| Return on sales | -35.05% | 0% | 0% | -23351.25% |
| Return on invested capital | -24.81% | 0% | 0% | -301.3% |
| Profitability | 25% | 0% | 75% | 0% |
| Total debt ratio | 84.17% | 0% | 0% | 105.86% |
| Debt ratio change over time | 8.67% | 0% | 0% | -1.68% |
| Dept financing | 45% | 0% | 0% | 25% |
| Current Ratio | 2.42% | 0% | 0% | 6.21% |
| Quick Ratio | 2.42% | 0% | 0% | 6.2% |
| Cash Position Ratio | 2.16% | 0% | 0% | 5.92% |
| Liquididy | 29% | 0% | 0% | 75% |